Glypican-3, a novel prognostic marker of hepatocellular cancer, is related with postoperative metastasis and recurrence in hepatocellular cancer patients

Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma

(2009) Hirofumi Shirakawa et al.   CANCER SCIENCE

Survival Analysis of Patients With Transplantable Recurrent Hepatocellular Carcinoma

(2008) Kelvin K. Ng   ARCHIVES OF SURGERY

Anti-glypican 3 antibodies cause ADCC against human hepatocellular carcinoma cells

(2008) Kiyotaka Nakano et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Glypican-3 regulates migration, adhesion and actin cytoskeleton organization in mammary tumor cells through Wnt signaling modulation

(2008) Ivan Stigliano et al.   BREAST CANCER RESEARCH AND TREATMENT

Anti-Glypican 3 Antibody as a Potential Antitumor Agent for Human Liver Cancer

(2008) T. Ishiguro et al.   CANCER RESEARCH

Human homolog of NOTUM, overexpressed in hepatocellular carcinoma, is regulated transcriptionally by β-catenin/TCF

(2008) Yuichi Torisu et al.   CANCER SCIENCE

Overexpression of Tiam1 in hepatocellular carcinomas predicts poor prognosis of HCC patients

(2008) Yi Ding et al.   INTERNATIONAL JOURNAL OF CANCER

Glypicans

(2008) Jorge Filmus et al.   GENOME BIOLOGY

Expression of glypican 3 in hepatoblastoma: an immunohistochemical study of 65 cases

(2007) Debra L. Zynger et al.   HUMAN PATHOLOGY

Hepatocellular carcinoma: Epidemiology and clinical aspects

(2007) Roberto Mazzanti et al.   MOLECULAR ASPECTS OF MEDICINE